212 related articles for article (PubMed ID: 34641958)
1. CM from intact hAM: an easily obtained product with relevant implications for translation in regenerative medicine.
Silini AR; Papait A; Cargnoni A; Vertua E; Romele P; Bonassi Signoroni P; Magatti M; De Munari S; Masserdotti A; Pasotti A; Rota Nodari S; Pagani G; Bignardi M; Parolini O
Stem Cell Res Ther; 2021 Oct; 12(1):540. PubMed ID: 34641958
[TBL] [Abstract][Full Text] [Related]
2. Comparison of EV-free fraction, EVs, and total secretome of amniotic mesenchymal stromal cells for their immunomodulatory potential: a translational perspective.
Papait A; Ragni E; Cargnoni A; Vertua E; Romele P; Masserdotti A; Perucca Orfei C; Signoroni PB; Magatti M; Silini AR; De Girolamo L; Parolini O
Front Immunol; 2022; 13():960909. PubMed ID: 36052081
[TBL] [Abstract][Full Text] [Related]
3. B Lymphocytes as Targets of the Immunomodulatory Properties of Human Amniotic Mesenchymal Stromal Cells.
Magatti M; Masserdotti A; Bonassi Signoroni P; Vertua E; Stefani FR; Silini AR; Parolini O
Front Immunol; 2020; 11():1156. PubMed ID: 32582218
[TBL] [Abstract][Full Text] [Related]
4. Amniotic membrane mesenchymal cells-derived factors skew T cell polarization toward Treg and downregulate Th1 and Th17 cells subsets.
Pianta S; Bonassi Signoroni P; Muradore I; Rodrigues MF; Rossi D; Silini A; Parolini O
Stem Cell Rev Rep; 2015 Jun; 11(3):394-407. PubMed ID: 25348066
[TBL] [Abstract][Full Text] [Related]
5. Amniotic mesenchymal cells from pre-eclamptic placentae maintain immunomodulatory features as healthy controls.
Pianta S; Magatti M; Vertua E; Bonassi Signoroni P; Muradore I; Nuzzo AM; Rolfo A; Silini A; Quaglia F; Todros T; Parolini O
J Cell Mol Med; 2016 Jan; 20(1):157-69. PubMed ID: 26515425
[TBL] [Abstract][Full Text] [Related]
6. Human amniotic mesenchymal stem cells and their paracrine factors promote wound healing by inhibiting heat stress-induced skin cell apoptosis and enhancing their proliferation through activating PI3K/AKT signaling pathway.
Li JY; Ren KK; Zhang WJ; Xiao L; Wu HY; Liu QY; Ding T; Zhang XC; Nie WJ; Ke Y; Deng KY; Liu QW; Xin HB
Stem Cell Res Ther; 2019 Aug; 10(1):247. PubMed ID: 31399039
[TBL] [Abstract][Full Text] [Related]
7. Amnion-Derived Mesenchymal Stromal/Stem Cell Paracrine Signals Potentiate Human Liver Organoid Differentiation: Translational Implications for Liver Regeneration.
Lo Nigro A; Gallo A; Bulati M; Vitale G; Paini DS; Pampalone M; Galvagno D; Conaldi PG; Miceli V
Front Med (Lausanne); 2021; 8():746298. PubMed ID: 34631757
[TBL] [Abstract][Full Text] [Related]
8. Anti-Inflammatory and Anti-Fibrotic Effects of Human Amniotic Membrane Mesenchymal Stem Cells and Their Potential in Corneal Repair.
Navas A; Magaña-Guerrero FS; Domínguez-López A; Chávez-García C; Partido G; Graue-Hernández EO; Sánchez-García FJ; Garfias Y
Stem Cells Transl Med; 2018 Dec; 7(12):906-917. PubMed ID: 30260581
[TBL] [Abstract][Full Text] [Related]
9. Amniotic membrane-mesenchymal stromal cells secreted factors and extracellular vesicle-miRNAs: Anti-inflammatory and regenerative features for musculoskeletal tissues.
Ragni E; Papait A; Perucca Orfei C; Silini AR; Colombini A; Viganò M; Libonati F; Parolini O; de Girolamo L
Stem Cells Transl Med; 2021 Jul; 10(7):1044-1062. PubMed ID: 33656805
[TBL] [Abstract][Full Text] [Related]
10. In vitro osteodifferentiation of intact human amniotic membrane is not beneficial in the context of bone repair.
Gualdi T; Laurent R; Moutarlier V; Fenelon M; Nallet A; Pouthier F; Obert L; de Billy B; Meyer C; Gindraux F
Cell Tissue Bank; 2019 Sep; 20(3):435-446. PubMed ID: 31209623
[TBL] [Abstract][Full Text] [Related]
11. Mesenchymal Stromal Cells from Fetal and Maternal Placenta Possess Key Similarities and Differences: Potential Implications for Their Applications in Regenerative Medicine.
Papait A; Vertua E; Magatti M; Ceccariglia S; De Munari S; Silini AR; Sheleg M; Ofir R; Parolini O
Cells; 2020 Jan; 9(1):. PubMed ID: 31935836
[TBL] [Abstract][Full Text] [Related]
12. Immunomodulatory effects of human amniotic membrane-derived mesenchymal stem cells.
Kang JW; Koo HC; Hwang SY; Kang SK; Ra JC; Lee MH; Park YH
J Vet Sci; 2012 Mar; 13(1):23-31. PubMed ID: 22437532
[TBL] [Abstract][Full Text] [Related]
13. Conditioned medium from amniotic cells protects striatal degeneration and ameliorates motor deficits in the R6/2 mouse model of Huntington's disease.
Giampà C; Alvino A; Magatti M; Silini AR; Cardinale A; Paldino E; Fusco FR; Parolini O
J Cell Mol Med; 2019 Feb; 23(2):1581-1592. PubMed ID: 30585395
[TBL] [Abstract][Full Text] [Related]
14. Human amniotic membrane-derived stromal cells (hAMSC) interact depending on breast cancer cell type through secreted molecules.
Kim SH; Bang SH; Kang SY; Park KD; Eom JH; Oh IU; Yoo SH; Kim CW; Baek SY
Tissue Cell; 2015 Feb; 47(1):10-6. PubMed ID: 25441616
[TBL] [Abstract][Full Text] [Related]
15. Tissue engineering for neurodegenerative diseases using human amniotic membrane and umbilical cord.
Sanluis-Verdes A; Sanluis-Verdes N; Manso-Revilla MJ; Castro-Castro AM; Pombo-Otero J; Fraga-Mariño M; Sanchez-Ibañez J; Doménech N; Rendal-Vázquez ME
Cell Tissue Bank; 2017 Mar; 18(1):1-15. PubMed ID: 27830445
[TBL] [Abstract][Full Text] [Related]
16. Amniotic Mesenchymal Stromal Cells Exhibit Preferential Osteogenic and Chondrogenic Differentiation and Enhanced Matrix Production Compared With Adipose Mesenchymal Stromal Cells.
Topoluk N; Hawkins R; Tokish J; Mercuri J
Am J Sports Med; 2017 Sep; 45(11):2637-2646. PubMed ID: 28541092
[TBL] [Abstract][Full Text] [Related]
17. Carcinogenicity, efficiency and biosafety analysis in xeno-free human amniotic stem cells for regenerative medical therapies.
Phermthai T; Thongbopit S; Pokathikorn P; Wichitwiengrat S; Julavijitphong S; Tirawanchai N
Cytotherapy; 2017 Aug; 19(8):990-1001. PubMed ID: 28566211
[TBL] [Abstract][Full Text] [Related]
18. Changes in the Transcriptome Profiles of Human Amnion-Derived Mesenchymal Stromal/Stem Cells Induced by Three-Dimensional Culture: A Potential Priming Strategy to Improve Their Properties.
Gallo A; Cuscino N; Contino F; Bulati M; Pampalone M; Amico G; Zito G; Carcione C; Centi C; Bertani A; Conaldi PG; Miceli V
Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35055049
[TBL] [Abstract][Full Text] [Related]
19. Immunomodulatory Properties of Amniotic Membrane Derivatives and Their Potential in Regenerative Medicine.
Wassmer CH; Berishvili E
Curr Diab Rep; 2020 Jun; 20(8):31. PubMed ID: 32519069
[TBL] [Abstract][Full Text] [Related]
20. The Immunomodulatory Properties of the Human Amnion-Derived Mesenchymal Stromal/Stem Cells Are Induced by INF-γ Produced by Activated Lymphomonocytes and Are Mediated by Cell-To-Cell Contact and Soluble Factors.
Bulati M; Miceli V; Gallo A; Amico G; Carcione C; Pampalone M; Conaldi PG
Front Immunol; 2020; 11():54. PubMed ID: 32117234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]